Everand Logo

Welcome to Everand!

  • Time Magazine International Edition

    The Coronavirus Brief

    Sep 03, 2022 2 minutes
    By Jamie Ducharme / HEALTH CORRESPONDENT

    PAXLOVID, THE ANTIVIRAL DRUG touted for its ability to keep high-risk COVID-19 patients out of the hospital, works very well for seniors but provides little benefit for people younger than 65, concluded the authors of a study published in the New England Journal of Medicine in August.

    For the

    You’re reading a preview, subscribe to read more.

    More from Time Magazine International Edition

    Time Magazine International Edition7 min read
    Innovators
    In 2020, for every 100,000 Nigerian women who gave birth, about 1,000 did not survive, according to the World Health Organization (WHO). Hadiza Galadanci, a professor of obstetrics and gynecology at Nigeria’s Bayero University, knows that problem all
    Time Magazine International Edition2 min read
    A Man In Full, Adapted And Redacted
    Tom Wolfe’s A Man in Full is a massive book, in more ways than one. The 742-page social novel about a swaggering Atlanta real estate mogul, which took Wolfe over a decade to write, sold a jaw-dropping 1.4 million hardcover copies after its publicatio
    Time Magazine International Edition1 min read
    The D.C. Brief
    Rare is the member of Congress who represents a district that voted for the other party’s nominee for President. Gerrymandering has rendered those political survivors harder to find than unicorns, while reducing truly competitive House districts to s

    Related Books & Audiobooks